Shady Fadel

Shady Fadel

Auto-generated profile, based on publicly available information

Shady Fadel

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Faculty of Medicine, Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2017 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
HMHebatAlla Fathi Mohamed Mousa
HebatAlla Fathi Mohamed Mousa
NANesrin Kamal Abd-El-Fatah
Nesrin Kamal Abd-El-Fatah
ODOlfat Abdel-Hamid Darwish
Olfat Abdel-Hamid Darwish
SSShehata Farag Shehata
Shehata Farag Shehata
SFShady Hassan Fadel
Shady Hassan Fadel

1 September 2014 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
NGNoha M. Gwili
Noha M. Gwili
MHMona A. Hadi
Mona A. Hadi
AEAmina N. Eldin
Amina N. Eldin
HHHoda M. Hassab
Hoda M. Hassab
YEYasser S. Eldin
Yasser S. Eldin
NMNagwa A. Mashali
Nagwa A. Mashali
Assessment of lymphadenopathy in children represents a diagnostic challenge because of the extensive differential diagnoses, including reactive and malignant conditions. Knowledge of the etiologic pattern of lymphadenopathy in a given geographical region is essential for making a confident diagnosis or for suspecting a disease. Hence, the present study was carried out to identify different etiologies of lymphadenopathy in children in our region and to assess parameters commonly associated with malignancy, with an emphasis on the role of pathology. One hundred and twenty patients aged 1 month to 18 years were included in the study. They were sorted into neoplastic and nonneoplastic (infectious and noninfectious) groups. In 56 patients, biopsy (fine needle aspiration cytology [FNAC], core needle, or excision biopsy) was essential to reach the final diagnosis. Sensitivity of FNAC in the differentiation between neoplastic and nonneoplastic lymphadenopathy was 92.3%, and specificity was 90.0%, with a diagnostic accuracy of 91.3%. We concluded that malignancy should be suspected in the following conditions: presence of abdominal or multiple symptoms; symptom duration of 1–6 months; generalized lymphadenopathy; multiple groups of lymph node (LN) involved; LN size > 2 cm; amalgamated, hard, fixed, and nontender LNs; certain abnormal complete blood count findings; blast cells in blood film; and elevated lactate dehydrogenase level. In such cases, LN biopsy is highly recommended. A final diagnosis was achieved after integrating information from history and clinical findings with the laboratory, radiological, pathological, and microbiological findings. Accordingly, an algorithm for primary diagnostic evaluation of children with lymphadenopathy is suggested.

2 March 2016 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
WAWessam M. Amin
Wessam M. Amin
HKHesham T. Kotb
Hesham T. Kotb
AAAli A. Abdel-Kerim
Ali A. Abdel-Kerim
MBMohamed S. Barakat
Mohamed S. Barakat
AEAwad A. El-Malky
Awad A. El-Malky
SFShady H. Fadel
Shady H. Fadel
Purpose To evaluate the role of diffusion-weighted apparent diffusion coefficient (ADC) and in-phase/opposed-phase sequences in the differentiation of benign and malignant osseous tumors. Materials and Methods At 1.5T, routine sequences were compared to diffusion-weighted and in-phase/opposed-phase in 63 patients. Routine sequence magnetic resonance imaging (MRI) scoring, mean ADC value, and in-phase/opposed-phase signal intensity ratio (SIR) was obtained. Statistical analysis included significance, receiver operating characteristic (ROC), and linear correlation between the three parameters. Results In all, 38 patients had malignant tumors and 25 patients had benign tumors. Benign and malignant tumors showed different routine sequence scores (P < 0.001). Mean ADC of the benign lesions ranged 0.9–3.2 × 10−3mm2/sec of mean ± SD (1.9 ± 0.6). In malignant tumors, the mean ADC ranged 0.6–1.9 × 10−3mm2/sec of mean ± SD (1.1 ± 0.4) (P < 0.0001). There was a possible differentiation between malignant and benign tumors at a threshold of 1.1 × 10−3mm2/sec of sensitivity and specificity of 94.1% and 70.3%, respectively. SIR for benign tumors ranged 0.2–1.0 of mean ± SD (0.6 ± 0.3). For malignant lesions SIR ranged 0.4–1.2 of mean ± SD (0.8 ± 0.3). Benign and malignant tumors show statistically significant SIR at P < 0.022 with possible differentiation at a threshold of 0.75 of sensitivity and specificity of 70.3% and 76.5%, respectively. Simple linear correlation between both ADC and SIR was significant at P < 0.01 with correlation coefficient (r) = 0.45. Conclusion Diffusion-weighted and in-phase/opposed-phase imaging might be used in addition to conventional MRI as a routine tool for differentiation of benign and malignant tumors. J. Magn. Reson. Imaging 2016;44:565–572.

1 September 2015 in Physica Medica
Verified
Journal Article
Closed access
PDF file
DZD.M. AL Zayat
D.M. AL Zayat
EAE.M. Attalla
E.M. Attalla
HAH.S. Abouelenein
H.S. Abouelenein
SFS. Fadel
S. Fadel
WKW. Khalil
W. Khalil

1 December 2014 in Alexandria Journal of Medicine
Verified
Journal Article
Open access
AHAzza Helal
Azza Helal
MMMohamed Farouk Mostafa
Mohamed Farouk Mostafa
RERasha Elsaka
Rasha Elsaka
SFShady Fadel
Shady Fadel
IntroductionRadiotherapy of the posterior fossa is routinely delivered using 3DCRT parallel-opposed lateral fields. However high incidence of sensorineural hearing loss, hypothalamic–pituitary dysfunction, thyroid and gonadal dysfunction during radiotherapy makes the need for treatment plan which provides adequate coverage of the target volume while sparing of the cochlea and other surrounding organs at risk (OARs) at same time inevitable.Aim of the workTo compare the coverage of posterior fossa and the dose to surrounding OARs including non-posterior fossa brain, pituitary, cochlea, eyes, optic nerves, optic chiasm, cervical spinal cord, thyroid gland, pharynx, parotid glands and mandible using three different 3DCRT plans.MethodsTen patients underwent CT simulation for treatment planning of posterior fossa boost. The CT data were transferred to Precise Elekta treatment planning system where posterior fossa, non-posterior fossa brain, pituitary, cochlea, parotid glands, cervical spinal cord, thyroid gland, pharynx, mandible, eyes, lenses, optic nerves and optic chiasm were all contoured.For each patient, three plans were carried out; two parallel opposed open lateral photon fields, a pair of wedged posterior oblique fields, and a pair of wedged posterior oblique fields and an open vertex field.For all plans, the dose distributions and dose volume histogram parameters (DVPs) for the PTV and OARs were compared and analyzed statistically using excel sheet 2003 and SPSS spreadsheet (SPSS base 18).ResultsPosterior fossa dose coverage and its homogeneity were adequate and comparable for the three plans. A part from high mean dose received by cochlea, plan 1 shows the best sparing for other OARs.Conclusion3DCRT using parallel opposed fields is recommended for posterior fossa irradiation boost as it minimizes the exit dose to all structures other than the cochlea, however its mean dose was within the tolerance

30 July 2014 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
NGNoha Gwili
Noha Gwili
MAMona Abdel-Hadi
Mona Abdel-Hadi
ANAmina Nour-Eldin
Amina Nour-Eldin
HHHoda Hassab
Hoda Hassab
YEYasser Saad ElDin
Yasser Saad ElDin
NMNagwa Mashali
Nagwa Mashali
Assessment of lymphadenopathy in children represents a diagnostic challenge because of the extensive differential diagnoses including reactive and malignant conditions. Knowledge of the etiologic pattern of lymphadenopathy in a given geographical region is essential for making a confident diagnosis or suspecting a disease. Hence, the present study was carried out to identify different etiologies of lymphadenopathy in children in our region, and assess parameters commonly associated with malignancy, with an emphasis on the role of pathology in the diagnostic workup. One hundred and twenty patients aged one month to 18 years were included in the study. They were sorted into neoplastic and non-neoplastic (Infectious and non-infectious). In only 56 patients, biopsy, whether fine needle aspiration cytology (FNAC), core needle or excision biopsy, was essential to reach the final diagnosis. Sensitivity of FNAC in the differentiation between neoplastic and non-neoplastic lymphadenopathy was 92.3%, specificity 90.0%, with a diagnostic accuracy of 91.3%. We concluded that malignancy should be suspected in the following conditions: presence of abdominal or multiple symptoms, symptoms duration of 1-6 months, generalized lymphadenopathy, multiple groups of lymph node (LN) involved, LN size > 2 cm, amalgamated, hard, fixed and non-tender LNs, certain abnormal CBC findings, blast cells in blood film and elevated LDH level. In such cases, LN biopsy is highly recommended. A final diagnosis was achieved after integrating information from history and clinical findings with those of the laboratory, radiological, pathological and microbiological findings. Accordingly, an algorithm for primary diagnostic evaluation of children with lymphadenopathy is suggested.